ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1083

Outcomes of COVID-19 Illness in Systemic Autoinflammatory Diseases and Changes in Flares During the COVID-19 Pandemic: An International Survey

Samira Nazzar Romero1, Lakshmi Moorthy2, Jennifer Tousseau3, Sivia Lapidus4, Mariana Correia Marques5, Leanne Mansfield6, Marinka Twilt7, Grant Schulert8, Maria Gutierrez9, Saskya Angevare10, Fatma Dedeoglu11 and Karen Durrant12, 1University of California Los Angeles, Los Angeles, CA, 2Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 3Autoinflamamtory Alliance, Lincoln, CA, 4The Joseph M. Sanzari Children's Hospital, Hackensack Meridian Health, Montclair, NJ, 5UPMC Children`s Hospital of Pittsburgh, Pittsburgh, PA, 6Hospital for Special Surgery, New York, NY, 7Alberta Children's Hospital, Calgary, AB, Canada, 8Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9John's Hopkins, Baltimore, MD, 10Autoinflammatory Alliance / Kaisz / ENCA as patient organizations, Amersfoort, Netherlands, 11Boston Children's Hospital, Boston, MA, 12Autoinflammatory Alliance, San Francisco, CA

Meeting: ACR Convergence 2021

Keywords: Autoinflammatory diseases, COVID-19, Miscellaneous Rheumatic and Inflammatory Diseases

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Session Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster II: Clinical Features & Diagnostics (1083–1117)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: The exaggerated inflammatory responses to the SARS-CoV-2 virus and the paucity of data on COVID-19 infection risk in systemic autoinflammatory disease (SAID) patients posed many unanswered questions, in addition to the profound overall impact of the pandemic.

The aim of this study is to determine if SAID patients had any changes in flare frequency or fevers during the COVID-19 pandemic, and to assess the outcome of SAID patients infected with the SARS-CoV-2 virus.

Methods: The CARRA Autoinflammatory Working Group collaborated with the Autoinflammatory Alliance to conduct an anonymous online survey which was distributed via social media and online autoinflammatory patient groups globally. Data collection was carried out from January 2021 through May 2021.

Results: A total of 647 surveys were completed. In those, 452 of the surveyed listed a specific SAID affecting them and/or their children. (Table 1)

Data for 593 patients showed that the frequency of flares (compared to pre-pandemic) were unchanged in 56% (n=334) of patients overall. The distribution of our data included 57% of patients from the United States, US territories and Canada and 70% of the international patients. Globally 54% of individuals reported that fevers during flares were either lower (n=31) or absent (n=58) since March 2020, and (n=31) found that their fevers were higher with flares. (Graphic 1) Most individuals were sheltering from work or school and 50% had no changes in their medication for SAID.

SARS-CoV-2 positivity occurred in 35 subjects. 20% (n=7) were asymptomatic, 40% (n=14) had mild infection, 31% (n=11) suffered with moderate illness at home and three (8%) were hospitalized in the regular ward. From the patients who contracted SARS-CoV-2, 31% (n=11) had a flare of their underlying SAID, either concurrently (20%, n=7) or after recovering from COVID-19 infection (11%; n=4). (Table 2) Ten (29%) SARS-CoV-2 positive patients reported lingering symptoms after resolution of acute COVID-19, such as headaches, fatigue, respiratory issues, myalgia and joint pain. Twenty patients reported physician-diagnosed presumed COVID-19, including a Neuro-Behçet’s patient requiring intensive care (ICU). Of these, 60% (n=12) had persistent symptoms post-COVID. One case of Multisystem Inflammatory Syndrome in children (MIS-C) and one case of Multisystem Inflammatory Syndrome in adults (MIS-A) with macrophage activation syndrome (MAS) occurred in patients with physician-diagnosed presumed COVID-19.

Conclusion: These data reflect the largest known global cohort of SAID patients’ experiences during the COVID-19 pandemic. Most patients had no change in flare frequency from their baseline SAID but many had a reduced intensity of their fevers during flares. The majority of SAID patients with COVID-19 infection reported mild to moderate illness with approximately a third who presented with an exacerbation of their baseline SAID with COVID-19 and lingering symptoms.

Table 1.jpeg”

Graphic 1.jpeg”


Disclosures: S. Nazzar Romero, None; L. Moorthy, Bristol Myers Squibb, 12, Site PI of Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis. (No personal reimbursement); J. Tousseau, None; S. Lapidus, None; M. Correia Marques, None; L. Mansfield, None; M. Twilt, None; G. Schulert, Novartis, 6; M. Gutierrez, None; S. Angevare, None; F. Dedeoglu, Novartis, 2, UptoDate, 9; K. Durrant, None.

To cite this abstract in AMA style:

Nazzar Romero S, Moorthy L, Tousseau J, Lapidus S, Correia Marques M, Mansfield L, Twilt M, Schulert G, Gutierrez M, Angevare S, Dedeoglu F, Durrant K. Outcomes of COVID-19 Illness in Systemic Autoinflammatory Diseases and Changes in Flares During the COVID-19 Pandemic: An International Survey [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/outcomes-of-covid-19-illness-in-systemic-autoinflammatory-diseases-and-changes-in-flares-during-the-covid-19-pandemic-an-international-survey/. Accessed February 6, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcomes-of-covid-19-illness-in-systemic-autoinflammatory-diseases-and-changes-in-flares-during-the-covid-19-pandemic-an-international-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences